International Society for the Study of Women's Sexual Health

NEWS

FDA announced a Public Advisory Committee Meeting

FDA announced a Public Advisory Committee Meeting to review the approval of flibanserin for hypoactive sexual desire disorder (HSDD) in women on June 4, 2015. Should you wish to submit your written comments or request time at the public microphone, the deadline is a week away. Please find all details in the Federal Register Notice by clicking on this link. - -

Save the Date

ISSWSH Fall Course 2018
November 15-17, 2018   24 days left
DoubleTree Hilton Hotel, Scottsdale, AZ - USA
Read more...

ISSWSH / ISSM Joint Meeting 2019
March 7-10, 2019   136 days left
Atlanta, GA, USA
Read more...

ISSWSH Annual Meeting 2020
March 5-8, 2020   500 days left
Renaissance Orlando at Seaworld, Orlando, FL, USA

Latest Tweets

Mind over matter: #FlashbackFriday to some historical debates over “vaginal rejuvenation” https://t.co/5QB0mbGEf6 ISSWSH
Fear factor? The relationship between fear-avoidance, pelvic floor muscle function and pain intensity in women with… https://t.co/vPFX75f0wc ISSWSH
ISSWSH Textbook of Female Sexual Function and Dysfunction now available for purchase! https://t.co/mhbyVVf12M ISSWSH

Contact Details

ISSWSH Executive Office
14305 Southcross Dr
Suite 100
Burnsville, MN 55306
USA

Phone: +1 (952) 683 9025
Fax: +1 (952) 314 8212
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.